Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01885728 · ClinicalTrials.gov registry record · NA
Immune-modulation Effects of an Arginine Rich Nutritional Supplement in Surgical Patients
A NA study, sponsored by Martin Angst.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT01885728: Completed NA study, sponsored by Martin Angst.
NCT01885728 is a NA study that has completed, run by Martin Angst. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01885728, a NA study, has completed, sponsored by Martin Angst.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The primary objective of this study is to characterize the immune-modulatory effects of arginine-rich nutritional supplements in patients undergoing surgery. Numerical and functional changes of all circulating immune cells will be assessed with mass cytometry.
Primary Outcome
The fraction of MDSCs will be quantified.
Interventions
- DIETARY_SUPPLEMENT An arginine rich nutritional supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2013-07 |
| Est. Completion | 2016-06 |
| Phase | NA |
What the finished NCT01885728 record still lists
NCT01885728 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which An arginine rich nutritional supplement is the first listed.
NCT01885728 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01885728 about?
NCT01885728 is a clinical study titled "Immune-modulation Effects of an Arginine Rich Nutritional Supplement in Surgical Patients". The primary objective of this study is to characterize the immune-modulatory effects of arginine-rich nutritional supplements in patients undergoing surgery. Numerical and functional changes of all circulating immune cells will be assessed with mass cytometry.
What is the current status of trial NCT01885728?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2013-07. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01885728?
The interventions under investigation include: An arginine rich nutritional supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01885728?
This trial is sponsored by Martin Angst, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01885728's enrollment target sits among peer trials
22 1756th of 2000 higher than 239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia